Measurement of health status in children with juvenile rheumatoid arthritis
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Objective. To develop and validate a self‐ or parent‐administered instrument for measuring functional status in children with juvenile rheumatoid arthritis (JRA). Methods. We adapted the Stanford Health Assessment Questionnaire (HAQ) for use in children ages 1–19 years, by adding several new questions, such that for each functional area, there was at least 1 question relevant to children of all ages. The face validity of the instrument was evaluated by a group of 20 health professionals and parents of 22 healthy children. The questionnaire was then administered to parents of 72 JRA patients (mean age 9.1 years, onset type systemic in 16, polyarticular in 21, pauciarticular in 35). Results. The instrument showed excellent internal reliability (Cronbach's α = 0.94), with a mean inter‐item correlation of 0.6. The convergent validity was demonstrated by strong correlations of the Disability Index (average of scores on all functional areas) with Steinbrocker functional class (Kendall's tau b = 0.77, P < 0.0001), number of involved joints (Kendall's tau b = 0.67, P < 0.0001), and morning stiffness (Kendall's tau b = 0.54, P < 0.0001). Spearman's correlation coefficient between Disability Index scores from questionnaires administered to parents and those from questionnaires administered to older children (>8 years) was 0.84 (n = 29; P < 0.001), showing that parents can accurately report for their children. The test–retest reliability, studied at a 2‐week interval, revealed virtually identical Disability Index scores measured on the 2 occasions (0.96 versus 0.96; P > 0.9 by paired t‐test; Spearman's correlation coefficient = 0.8, P < 0.002). Conclusion. The Childhood HAQ, which takes less than 10 minutes to complete, is a valid, reliable, and sensitive instrument for measuring functional status in children with JRA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Measurement of patient outcome in arthritis
Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230202 · Cited by 4,382
Self-citationTHERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITIS
STEINBROCKER, O. (1949) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1949.02900430001001 · Cited by 2,877
Measuring health status in arthritis
Meenan, R. F., Gertman, P. M., & Mason, J. H. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230203 · Cited by 1,176
The Denver Developmental Screening Test
Frankenburg, W. K., & Dodds, J. B. (1967) · The Journal of Pediatrics · doi:10.1016/s0022-3476(67)80070-2 · Cited by 1,068
Brewer, E. J., Bass, J., Baum, J., Cassidy, J. T., Fink, C., Jacobs, J. W. G., Hanson, V., Levinson, J. E., SCHALLER, J. G., & Stillman, J. S. (1977) · PubMed · Cited by 631
The health assessment questionnaire 1992. Status and review
Ramey, D. R., Raynauld, J., & Fries, J. F. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1790050303 · Cited by 332
Self-citationChambers, L. W., Macdonald, L. A., Tugwell, P., Buchanan, W. W., & Kraag, G. (1982) · PubMed · Cited by 211
Howe, S., Levinson, J., Shear, E., Hartner, S., McGirr, G., Schulte, M., & Lovell, D. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340713 · Cited by 185
Lovell, D. J., Shear, E., Hartner, S., McGirr, G., Schulte, M., Levinson, J., & Howe, S. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780321107 · Cited by 171
The AIMS approach to health status measurement: conceptual background and measurement properties.
Meenan, R. F. (1982) · PubMed · Cited by 161
Research works printed but not linked: 4
- Cassidy JT, 1993, Juvenile rheumatoid arthritis, Textbook of Rheumatology
- Rhodes VJ, 1988, Development of a functional assessment tool for children with juvenile rheumatoid arthritis (abstract), Arthritis Rheum, 31, S151
- Brewer EJ, 1977, Current proposed revision of JRA criteria, Arthritis Rheum, 20, 195
- Liang MH, 1990, Chronic rheumatic disease, Quality of Life Assessments in Clinical Trials
Cited by
Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis
Lovell, D. J., Giannini, E. H., Reiff, A., Cawkwell, G. D., Silverman, E. D., Nocton, J. J., Stein, L. D., Gedalia, A., Ilowite, N. T., Wallace, C. A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003163421103 · Cited by 1,246
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis
De Benedetti, F., Brunner, H. I., Ruperto, N., Kenwright, A., Wright, S., Calvo, I., Cuttica, R., Ravelli, A., Schneider, R., Woo, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112802 · Cited by 763
The Stanford Health Assessment Questionnaire: dimensions and practical applications.
Bruce, B., & Fries, J. F. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-20 · Cited by 812
Self-citationDevelopment and validation of a composite disease activity score for juvenile idiopathic arthritis
Consolaro, A., Ruperto, N., Bazso, A., Pistorio, A., Magni‐Manzoni, S., Filocamo, G., Malattia, C., Viola, S., Martini, A., & Ravelli, A. (2009) · Arthritis Care & Research · doi:10.1002/art.24516 · Cited by 788
“Changes in JADAS in relation to changes in C-HAQ, DAS28, and CDAI scores.”
MethodInfluentialBruce, B., & Fries, J. F. (2003) · PubMed · Cited by 753
Self-citationPhenotype and Course of Hutchinson–Gilford Progeria Syndrome
Merideth, M. A., Gordon, L. B., Clauss, S., Sachdev, V., Smith, A. C. M., Perry, M. B., Brewer, C. C., Zalewski, C., Kim, H. J., Solomon, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706898 · Cited by 743
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Ruperto, N., Brunner, H. I., Quartier, P., Constantin, T., Wulffraat, N., Horneff, G., Brik, R., McCann, L., Kasapcopur, O., Rutkowska-Sak, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205099 · Cited by 713
Oddis, C. V., Reed, A. M., Aggarwal, R., Rider, L. G., Ascherman, D. P., Levesque, M. C., Barohn, R. J., Feldman, B. M., Harris‐Love, M. O., Koontz, D. C., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37754 · Cited by 701
Solans, M., Pane, S., Estrada, M.-D., Serra-Sutton, V., Berra, S., Herdman, M., Alonso, J., & Rajmil, L. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00293.x · Cited by 644
Ruperto, N., Lovell, D. J., Quartier, P., Paz, E., Rubio-Pérez, N., Silva, C. A., Abud-Mendoza, C., Burgos-Vargas, R., Gerloni, V., Melo-Gomes, J. A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60998-8 · Cited by 560
Wraith, J. E., Clarke, L. A., Beck, M., Kolodny, E. H., Pastores, G. M., Muenzer, J., Rapoport, D. M., Berger, K. I., Swiedler, S. J., Kakkis, E. D., et al. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.01.046 · Cited by 547
Varni, J. W., Seid, M., Smith Knight, T., Burwinkle, T., Brown, J., & Szer, I. S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10095 · Cited by 535
Rider, L. G., Werth, V. P., Huber, A. M., Alexanderson, H., Rao, A. P., Ruperto, N., Herbelin, L., Barohn, R., Isenberg, D., & Miller, F. W. (2011) · Arthritis Care & Research · doi:10.1002/acr.20532 · Cited by 430
“The C-HAQ was adapted directly from the HAQ and was first published in 1994 (20).”
Ruperto, N., Lovell, D. J., Cuttica, R., Wilkinson, N., Woo, P., Espada, G., Wouters, C., Silverman, E. D., Balogh, Z., Henrickson, M., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22838 · Cited by 410
Primeau, Kagan, Joseph, Lim, Dufresne, Duffy, Prhcal, & Clarke (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00889.x · Cited by 403
Ruperto, N., Murray, K. J., Gerloni, V., Wulffraat, N., Feitosa De Oliveira, S. K., Falcini, F., Dolezalova, P., Alessio, M., Burgos‐Vargas, R., Corona, F., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20288 · Cited by 375
“The CHAQ ( 19 ,20) is a validated diseasespecific instrument for JIA adapted from the adult Health Assessment Questionnaire.”
MethodRuperto, N., Ravelli, A., Pistorio, A., Malattia, C., Cavuto, S., Gado-West, L., Tortorelli, A., Landgraf, J. M., Singh, G., & Martini, A. (2001) · PubMed · Cited by 337
Self-citationMartini, A., Lovell, D. J., Albani, S., Brunner, H. I., Hyrich, K. L., Thompson, S. D., & Ruperto, N. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00332-8 · Cited by 289
The German etanercept registry for treatment of juvenile idiopathic arthritis
Horneff, G., Schmeling, H., Biedermann, T., Foeldvari, I., Ganser, G., Girschick, H. J., Hospach, T., Huppertz, H. I., Keitzer, R., Küster, R. M., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014886 · Cited by 318
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis
Wallace, C. A., Giannini, E. H., Spalding, S. J., Hashkes, P. J., O'Neil, K. M., Zeft, A. S., Szer, I. S., Ringold, S., Brunner, H. I., Schanberg, L. E., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34343 · Cited by 312
“After the baseline visit, the following assessments were performed at every visit: joint examination, conducted in a blinded manner by a trained certified joint assessor (whose only contact with the patient was to conduct the joint assessment) to determine the number of joints with active arthritis and the number of j…”
MethodInfluentialFeldman, B. M., Funk, S. M., Bergstrom, B., Zourikian, N., Hilliard, P., van der Net, J., Engelbert, R., Petrini, P., van den Berg, H. M., Manco‐Johnson, M. J., et al. (2011) · Arthritis Care & Research · doi:10.1002/acr.20353 · Cited by 289
“dated for use in juvenile arthritis (22), but has subse-”
BackgroundSaurenmann, R. K., Levin, A. V., Feldman, B. M., Rose, J. B., Laxer, R. M., Schneider, R., & Silverman, E. D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22381 · Cited by 288
Ravelli, A., Trail, L., Ferrari, C., Ruperto, N., Pistorio, A., Pilkington, C., Maillard, S., Oliveira, S. K., Sztajnbok, F., Cuttica, R., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20015 · Cited by 279
“The following clinical assessments were performed at the cross-sectional visit: muscle strength and function/endurance through the 8-muscle Manual Muscle Testing (MMT; normal 80) by Kendall et al (14) and the Childhood Myositis Assessment Scale (CMAS; normal 52) (15), respectively; overall disease activity through the…”
MethodFrosch, M., Strey, A., Vogl, T., Wulffraat, N. M., Kuis, W., Sunderkötter, C., Harms, E., Sorg, C., & Roth, J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<628::aid-anr20>3.0.co;2-x · Cited by 381
Weiss, P. F., Arabshahi, B., Johnson, A., Bilaniuk, L. T., Zarnow, D., Cahill, A. M., Feudtner, C., & Cron, R. Q. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23401 · Cited by 273
“00 Unilateral 4 (17) 0 Bilateral 20 (83) 0 Chronic changes 22 (69) 9 (28) 50 0.”
BackgroundMethodInfluentialEnzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
Harmatz, P., Whitley, C. B., Waber, L., Pais, R., Steiner, R., Plecko, B., Kaplan, P., Simon, J., Butensky, E., & Hopwood, J. J. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.03.018 · Cited by 272
DeWalt, D. A., Gross, H. E., Gipson, D. S., Selewski, D. T., DeWitt, E. M., Dampier, C. D., Hinds, P. S., Huang, I.-C., Thissen, D., & Varni, J. W. (2015) · Quality of Life Research · doi:10.1007/s11136-015-0953-3 · Cited by 264
“We also collected the Childhood Health Assessment Questionnaire (CHAQ) [25], parental ratings of children's overall well-being, numeric rating scale of average pain intensity over the past seven days, and school days missed due to illness.”
InfluentialDisease activity score for children with juvenile dermatomyositis: Reliability and validity evidence
Bode, R. K., Klein‐Gitelman, M. S., Miller, M. L., Lechman, T. S., & Pachman, L. M. (2003) · Arthritis Care & Research · doi:10.1002/art.10924 · Cited by 257
Leflunomide or Methotrexate for Juvenile Rheumatoid Arthritis
Silverman, E., Mouy, R., Spiegel, L., Jung, L. K., Saurenmann, R. K., Lahdenne, P., Horneff, G., Calvo, I., Szer, I. S., Simpson, K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041810 · Cited by 260
Palermo, T. M., Long, A. C., Lewandowski, A. S., Drotar, D., Quittner, A. L., & Walker, L. S. (2008) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsn038 · Cited by 247
“986 Palermo et al. Downloaded from https://academic.oup.com/jpepsy/article-abstract/33/9/983/928358 by guest on 27 July 2018 Table I. Reliability and Validity of Generic, Condition-specific, and Functional Disability Measures Reviewed Measures Ages Respondents and response formats Psychometrics: reliability Psychometr…”
BackgroundInfluentialClinical outcome measures in juvenile idiopathic arthritis
Consolaro, A., Giancane, G., Schiappapietra, B., Davì, S., Calandra, S., Lanni, S., & Ravelli, A. (2016) · Pediatric Rheumatology · doi:10.1186/s12969-016-0085-5 · Cited by 245
“A wide variety of measures for the assessment of PCRO in children with JIA is currently available, ranging from VAS for rating of child’s overall well-being and intensity of pain, to questionnaires for the evaluation of functional ability and HRQOL [18, 53–59].”
BackgroundLovell, D. J., Giannini, E. H., Reiff, A., Jones, O. Y., Schneider, R., Olson, J. C., Stein, L. D., Gedalia, A., Ilowite, N. T., Wallace, C. A., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10710 · Cited by 250
Huber, A. M., Feldman, B. M., Rennebohm, R. M., Hicks, J. E., Lindsley, C. B., Perez, M. D., Zemel, L. S., Wallace, C. A., Ballinger, S. H., Passo, M. H., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20179 · Cited by 239
Flatø, B., Lien, G., Smerdel, A., Vinje, O., Dale, K., Johnston, V., Sørskaar, D., Moum, T., Płoski, R., & Førre, Ø. T. (2003) · PubMed · Cited by 239
Long‐term safety and efficacy of abatacept in children with juvenile idiopathic arthritis
Ruperto, N., Lovell, D. J., Quartier, P., Paz, E., Rubio‐Pérez, N., Silva, C. A., Abud‐Mendoza, C., Burgos‐Vargas, R., Gerloni, V., Melo‐Gomes, J. A., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27431 · Cited by 240
FELDMAN, B. M., PAI, M., RIVARD, G. E., ISRAELS, S., POON, M. ‐., DEMERS, C., ROBINSON, S., LUKE, K. ‐., WU, J. K. M., GILL, K., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01953.x · Cited by 239
“7 Physical disability as measured by the Childhood Health Assessment Questionnaire (CHAQ) [ 28 ].”
MethodRuperto, N., Pistorio, A., Oliveira, S., Zulian, F., Cuttica, R., Ravelli, A., Fischbach, M., Magnusson, B., Sterba, G., Avcin, T., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01021-1 · Cited by 240
Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosis
Gunawardena, H., Wedderburn, L. R., Chinoy, H., Betteridge, Z. E., North, J., Ollier, W. E. R., Cooper, R. G., Oddis, C. V., Ramanan, A. V., Davidson, J. E., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24547 · Cited by 234
“There was no significant difference between other clinical features when comparing anti-p140–positive patients and antip140–negative patients, including the baseline CK level, the CMAS score, the Childhood Health Assessment Questionnaire (C-HAQ) score (26), the physician’s global assessment scale (PGA) score, and the…”
BackgroundRuperto, N. (2003) · Rheumatology · doi:10.1093/rheumatology/keg403 · Cited by 234
International consensus on preliminary definitions of improvement in adult and juvenile myositis
Rider, L. G., Giannini, E. H., Brunner, H. I., Ruperto, N., James‐Newton, L., Reed, A. M., Lachenbruch, P. A., & Miller, F. W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20349 · Cited by 229
Beck, C., Morbach, H., Beer, M., Stenzel, M., Tappe, D., Gattenlöhner, S., Hofmann, U., Raab, P., & Girschick, H. J. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2992 · Cited by 228
“The CHAQ has shown to be a valid, reliable, and sensitive functional status measure in children with juvenile idiopathic arthritis [22].”
BackgroundConsolaro, A., Bracciolini, G., Ruperto, N., Pistorio, A., Magni‐Manzoni, S., Malattia, C., Pederzoli, S., Davì, S., Martini, A., Ravelli, A., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34373 · Cited by 227
Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
Muenzer, J., Beck, M., Eng, C. M., Giugliani, R., Harmatz, P., Martin, R., Ramaswami, U., Vellodi, A., Wraith, J. E., Cleary, M., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3181fea459 · Cited by 226
Sibley, C. H., Plass, N., Snow, J., Wiggs, E. A., Brewer, C. C., King, K. A., Zalewski, C., Kim, H. J., Bishop, R., Hill, S., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34409 · Cited by 220
“Scores for daily diaries, parent’s and physician’s global assessment of disease activity, parent’s assessment of pain, and C-HAQ decreased significantly from baseline to 36 months (P = 0.0016 for C-HAQ and P 0.001 for all other assessments).”
MethodInfluentialZulian, F., Martini, G., Vallongo, C., Vittadello, F., Falcini, F., Patrizi, A., Alessio, M., Torre, F. L., Podda, R. A., Gerloni, V., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30264 · Cited by 216
Harmatz, P., Ketteridge, D., Giugliani, R., Guffon, N., Teles, E. L., Miranda, M. C. S., Yu, Z.-F., Swiedler, S. J., Hopwood, J. J., & for the MPS VI Study Group (2005) · Pediatrics · doi:10.1542/peds.2004-1023 · Cited by 219
Llorente, L., Richaud-Patin, Y., García-Padilla, C., Claret, E., Jakez-Ocampo, J., Cardiel, M. H., Alcocer-Varela, J., Grangeot-Keros, L., Alarcón-Segovia, D., Wijdenes, J., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1790::aid-anr15>3.0.co;2-2 · Cited by 461
Enzyme replacement therapy: efficacy and limitations
Concolino, D., Deodato, F., & Parini, R. (2018) · Italian Journal of Pediatrics · doi:10.1186/s13052-018-0562-1 · Cited by 209
Daily pain and symptoms in children with polyarticular arthritis
Schanberg, L. E., Anthony, K. K., Gil, K. M., & Maurin, E. C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10986 · Cited by 209
Matsuda, Y., Singh, G., Yamanaka, H., Tanaka, E., Urano, W., Taniguchi, A., Saito, T., Hara, M., Tomatsu, T., & Kamatani, N. (2003) · Arthritis Care & Research · doi:10.1002/art.11465 · Cited by 203
Self-citationViola, S., Felici, E., Magni‐Manzoni, S., Pistorio, A., Buoncompagni, A., Ruperto, N., Rossi, F., Bartoli, M., Martini, A., & Ravelli, A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21119 · Cited by 194
Frosch, M., Ahlmann, M., Vogl, T., Wittkowski, H., Wulffraat, N., Foell, D., & Roth, J. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24349 · Cited by 190
“Collection of patient data included medical history and physical examination, number of joints with active disease, number of joints with limited range of motion (ROM), physician’s global assessment of disease activity, parent’s/patient’s assessment of overall well-being, and functional ability (as measured by the Chi…”
MethodFILOCAMO, G., CONSOLARO, A., SCHIAPPAPIETRA, B., DALPRÀ, S., LATTANZI, B., MAGNI-MANZONI, S., RUPERTO, N., PISTORIO, A., PEDERZOLI, S., CIVINO, A., et al. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100930 · Cited by 179
“(11) Listing of medications the child is taking.”
BackgroundMitochondrial disease in adults: A scale to monitor progression and treatment
Schaefer, A. M., Phoenix, C., Elson, J. L., McFarland, R., Chinnery, P. F., & Turnbull, D. M. (2006) · Neurology · doi:10.1212/01.wnl.0000219759.72195.41 · Cited by 178
Consolaro, A., Negro, G., Chiara Gallo, M., Bracciolini, G., Ferrari, C., Schiappapietra, B., Pistorio, A., Bovis, F., Ruperto, N., Martini, A., et al. (2014) · Arthritis Care & Research · doi:10.1002/acr.22393 · Cited by 175
“For the third approach, in patients from the second sample with a disease duration of 5 years (18), the proportion of patients with a cJADAS below the cutoffs for ID and LDA, in the interval corresponding to MDA, or above the cutoff for HDA was calculated in relation to the following: 1) the absence or presence of phy…”
MethodMonitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations
Foell, D., Wittkowski, H., Hammerschmidt, I., Wulffraat, N., Schmeling, H., Frosch, M., Horneff, G., Kuis, W., Sorg, C., & Roth, J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20125 · Cited by 177
Kowal‐Bielecka, O., Distler, O., Neidhart, M., K�nzler, P., Rethage, J., Nawrath, M., Carossino, A. M., Pap, T., M�ller-Ladner, U., Michel, B. A., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200108)44:8<1865::aid-art325>3.0.co;2-m · Cited by 44
Asfotase alfa therapy for children with hypophosphatasia
Whyte, M. P., Madson, K. L., Phillips, D., Reeves, A. L., McAlister, W. H., Yakimoski, A., Mack, K. E., Hamilton, K., Kagan, K., Fujita, K. P., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85971 · Cited by 174
“Secondary endpoint assessments included changes in TNSALP substrate levels (i.e., plasma PPi and PLP); growth (i.e., height, weight, and BMI Z scores); strength of muscle groups that move the hips and knees, measured using a hand-held dynamometer (21); walking ability and endurance/speed, using a 6MWT (22); physical f…”
MethodInfluentialMeasuring Quality of Life in Paediatric Patients
Connolly, M. A., & Johnson, J. A. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916060-00002 · Cited by 170
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
Lazarevic, D., Pistorio, A., Palmisani, E., Miettunen, P., Ravelli, A., Pilkington, C., Wulffraat, N. M., Malattia, C., Garay, S. M., Hofer, M., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201483 · Cited by 168
Ilowite, N. T., Prather, K., Lokhnygina, Y., Schanberg, L. E., Elder, M., Milojevic, D., Verbsky, J. W., Spalding, S. J., Kimura, Y., Imundo, L. F., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38699 · Cited by 167
“Sex Male 13 (36) 12 (34) Female 23 (64) 23 (66) Race Black 5 (14) 7 (20) White 25 (69) 23 (66) Other† 6 (17) 5 (14) Ethnicity Hispanic 7 (19) 5 (14) Non-Hispanic 29 (81) 30 (86) Age, years Mean SD 9.”
BackgroundInfluentialFILOCAMO, G., DAVÌ, S., PISTORIO, A., BERTAMINO, M., RUPERTO, N., LATTANZI, B., CONSOLARO, A., MAGNI-MANZONI, S., GALASSO, R., VARNIER, G. C., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091474 · Cited by 161
“The greater correlation between Parent Global and Parent Pain obtained with the use of the 10-cm horizontal line VAS may be due to the close proximity of these scales in the CHAQ, which may lead to a reciprocal influence between the 2 assessments 20 .”
MethodInfluentialRuperto, N., Ravelli, A., Pistorio, A., Ferriani, V., Calvo, I., Ganser, G., Brunner, J., Dannecker, G., Silva, C. A., Stanevicha, V., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23248 · Cited by 160
Swiedler, S. J., Beck, M., Bajbouj, M., Giugliani, R., Schwartz, I., Harmatz, P., Wraith, J. E., Roberts, J., Ketteridge, D., Hopwood, J. J., et al. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30579 · Cited by 161
“…of pain, and extent of disability were assessed using the Health Assessment Questionnaire (HAQ) [Fries, 1991; Ramey et al., 1992] for subjects older than 18 years of age, or Childhood Health Assessment Questionnaire (CHAQ) [Singh et al., 1994] completed by the caregiver of subjects 18 years of age.”
BackgroundMethodInfluentialGutierrez-Suarez, R., Pistorio, A., Cespedes Cruz, A., Norambuena, X., Flato, B., Rumba, I., Harjacek, M., Nielsen, S., Susic, G., Mihaylova, D., et al. (2006) · Rheumatology · doi:10.1093/rheumatology/kel218 · Cited by 164
“A parent of each patient (generally the mother) was asked to complete the national language version of the CHAQ [13, 16].”
BackgroundMethodOliveira, S., Ravelli, A., Pistorio, A., Castell, E., Malattia, C., Prieur, A. M., Saad‐Magalhães, C., Murray, K. J., Bae, S., Joos, R., et al. (2007) · Arthritis Care & Research · doi:10.1002/art.22473 · Cited by 158
“However, only a few of these measures are available in several languages (12,13), and for this reason the researchers of the Pediatric Rheumatology International Trials Organization (PRINTO) (14) have elected to cross-culturally adapt and validate the American English parent version of the Childhood Health Assessment…”
BackgroundBiologic therapy in refractory chronic non-bacterial osteomyelitis of childhood
Eleftheriou, D., Gerschman, T., Sebire, N. J., Woo, P. M., Pilkington, C., & Brogan, P. A. (2010) · Rheumatology · doi:10.1093/rheumatology/keq122 · Cited by 157
Haverman, L., Grootenhuis, M. A., van den Berg, J. M., van Veenendaal, M., Dolman, K. M., Swart, J. F., Kuijpers, T. W., & van Rossum, M. A. J. (2012) · Arthritis Care & Research · doi:10.1002/acr.21609 · Cited by 176
“Childhood Health Assessment Questionnaire (C-HAQ).”
MethodInfluentialRider, L. G., Miller, F. W., Feldman, B. M., Perez, M. D., Rennebohm, R. M., Lindsley, C. B., Zemel, L. S., Wallace, C. A., Ballinger, S. H., Bowyer, S. L., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401109 · Cited by 167
Ruperto, N., Lovell, D. J., Cuttica, R. J., Woo, P. M., Meiorin, S., Wouters, C. H., Silverman, E. D., Balogh, Z. J., Henrickson, M., Davidson, J. E., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.100354 · Cited by 150
“The key efficacy evaluation was the proportion of patients meeting the American College of Rheumatology Pediatric 30 (ACR-Pedi-30) response criteria”
Backgroundde Kleer, I. M., Brinkman, D. M. C., Ferster, A., Abinun, M., Quartier, P., van der Net, J. J., ten Cate, R., Wedderburn, L. R., Horneff, G., Oppermann, J., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.017798 · Cited by 158
Rider, L. G., Aggarwal, R., Pistorio, A., Bayat, N., Erman, B., Feldman, B. M., Huber, A. M., Cimaz, R., Cuttica, R. J., de Oliveira, S. K., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211401 · Cited by 149
“IMACS also includes the most abnormal serum muscle enzyme value and extramuscular global activity, whereas PRINTO includes instead a health-related quality of life measure, the Child Health Questionnaire (7) and a global activity score, the Disease Activity Score (8).”
BackgroundPreliminary definition of disease flare in juvenile rheumatoid arthritis.
Brunner, H. I., Lovell, D. J., Finck, B. K., & Giannini, E. H. (2002) · PubMed · Cited by 163
Sawyer, M. G. (2003) · Rheumatology · doi:10.1093/rheumatology/keh030 · Cited by 146
“Children’s level of functional disability was assessed by means of the Childhood Health Assessment Questionnaire (CHAQ) completed by parents [13].”
MethodBrinkman, D. M. C., de Kleer, I. M., Cate, R. T., van Rossum, M. A. J., Bekkering, W. P., Fasth, A. L., van Tol, M. J. D., Kuis, W., Wulffraat, N. M., & Vossen, J. M. J. J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22656 · Cited by 144
“Outcome measures included the following: 1) physician’s global assessment of overall disease activity as measured on a 10-cm visual analog scale (VAS), 2) parent’s/patient’s global assessment of overall well-being as measured on a 10-cm VAS, 3) functional ability as assessed on the Childhood Health Assessment Question…”
MethodAssociation of a Mutation in LACC1 With a Monogenic Form of Systemic Juvenile Idiopathic Arthritis
Wakil, S. M., Monies, D., Abouelhoda, M. I., Tassan, N. A. A., Al‐Dusery, H., Naim, E. A., Al‐Younes, B., Shinwari, J., Al-Mohanna, F. A., Meyer, B. F., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38877 · Cited by 156
“Imaging studies showed erosive arthritic changes with significant damage, mainly in the wrist and hip joints, with guarded functional capacity as measured by the Childhood Health Assessment Questionnaire (27), with a mean SD score of 1.25 0.99.”
BackgroundInfluentialWulffraat, N. M., Rijkers, G. T., Elst, E., Brooimans, R., & Kuis, W. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg074 · Cited by 146
Malattia, C., Damasio, M. B., Magnaguagno, F., Pistorio, A., Valle, M., Martinoli, C., Viola, S., Buoncompagni, A., Loy, A., Ravelli, A., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.24313 · Cited by 137
Horneff, G., Burgos‐Vargas, R., Constantin, T., Foeldvari, I., Vojinović, J., Chasnyk, V. G., Dehoorne, J., Panavienė, V., Sušić, G., Staņēviča, V., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203046 · Cited by 134
Angeles‐Han, S. T., Pelajo, C. F., Vogler, L. B., Rouster‐Stevens, K. A., Kennedy, C., Ponder, L. A., McCracken, C. M., Lopez‐Benitez, J. M., Drews‐Botsch, C., Prahalad, S., et al. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.130302 · Cited by 133
Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa
Kishnani, P. S., Rush, E. T., Arundel, P., Bishop, N. J., Dahir, K. M., Fraser, W. D., Harmatz, P., Linglart, A., Munns, C. F., Nuñes, M. E., et al. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.07.010 · Cited by 137
“6 months • Length, height, weight, and head circumference • Should be performed routinely by primary care physician Motor milestones Routine baseline, and then every 6 months • To be performed by PT/OT (BSID-III [62] or PDMS-2 [71] recommended, based on age) Mobility Baseline, 3 months, and then once a year • 6MWT (fo…”
MethodInfluentialSmith, T. O., Easton, V., Bacon, H., Jerman, E., Armon, K., Poland, F., & Macgregor, A. J. (2014) · Rheumatology · doi:10.1093/rheumatology/ket317 · Cited by 130
Long‐Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
Lovell, D. J., Giannini, E. H., Reiff, A. O., Kimura, Y., Li, S. C., Hashkes, P. J., Wallace, C. A., Onel, K. B., Foell, D., Wu, R., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38042 · Cited by 142
Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis
Oen, K. (2002) · Best Practice & Research Clinical Rheumatology · doi:10.1016/s1521-6942(02)90233-0 · Cited by 129
Stephens, S., Feldman, B. M., Bradley, N., Schneiderman, J., Wright, V., Singh‐Grewal, D., Lefebvre, A., Benseler, S. M., Cameron, B., Laxer, R., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.24115 · Cited by 125
Physical activity in adolescents with juvenile idiopathic arthritis
Lelieveld, O. T. H. M., Armbrust, W., Leeuwen, M. A. V., Duppen, N., Geertzen, J. H. B., Sauer, P. J. J., & van Weert, E. (2008) · Arthritis Care & Research · doi:10.1002/art.24102 · Cited by 135
“Functional ability. Functional ability was assessed with the validated Dutch translation of the Childhood Health Assessment Questionnaire (C-HAQ) ( 25 ,26).”
MethodAquatic fitness training for children with juvenile idiopathic arthritis
Takken, T., Net, J. V. D., Kuis, W., & Helders, P. J. M. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg386 · Cited by 128
“For the CHAQ and the JAFAS, mean scores and standard deviations of each group are presented in Table 2.”
MethodInfluentialWeiss, J. E., & Ilowite, N. T. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.01.007 · Cited by 145
Elena Garralda, M., & Rangel, L. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00244.x · Cited by 124
“Functional status in children with JIA was measured by a self-administered version of the Health Assessment Questionnaire (HAQ) adapted for this age group by Singh, Athreya, Fries, and Goldsmith (1994) .”
MethodEarly predictors of outcome in juvenile idiopathic arthritis.
Ravelli, A., & Martini, A. (2003) · PubMed · Cited by 121
Effectiveness of a Web-Based Application to Monitor Health-Related Quality of Life
Haverman, L., van Rossum, M. A. J., van Veenendaal, M., van den Berg, J. M., Dolman, K. M., Swart, J. F., Kuijpers, T. W., & Grootenhuis, M. A. (2013) · PEDIATRICS · doi:10.1542/peds.2012-0958 · Cited by 120
Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis.
Bowyer, S. L., Roettcher, P. A., Higgins, G. C., Adams, B. S., Myers, L. K., Wallace, C. A., Rennebohm, R. M., Moore, T. L., Pepmueller, P. H., Spencer, C. H., et al. (2003) · PubMed · Cited by 117
Robinson, A. B., Hoeltzel, M. F., Wahezi, D. M., Becker, M. L., Kessler, E. A., Schmeling, H., Carrasco, R., Huber, A. M., Feldman, B. M., Reed, A. M., et al. (2013) · Arthritis Care & Research · doi:10.1002/acr.22142 · Cited by 116
“Scale (CMAS; normal score 52) (8), the Childhood Health Assessment Questionnaire (C-HAQ; where 0 normal and 3 worst) (9,10), health-related quality of life measure (11), the American College of Rheumatology (ACR) functional class rating (12), global disease assessments, and pain scores (range 0–10, where 10 worst pain…”
BackgroundSingh‐Grewal, D., Schneiderman‐Walker, J., Wright, F. V., Bar‐Or, O., Beyene, J., Selvadurai, H. C., Cameron, B., Laxer, R. M., Schneider, R., Silverman, E. D., et al. (2007) · Arthritis Care & Research · doi:10.1002/art.23008 · Cited by 124
Parini, R., & Deodato, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082975 · Cited by 120
Sanner, H., Gran, J. T., Sjaastad, I., & Flatø, B. (2009) · Rheumatology · doi:10.1093/rheumatology/kep302 · Cited by 114
Waters, E. B., Salmon, L., Wake, M. A., Wright, M., & Hesketh, K. D. (2001) · Journal of Adolescent Health · doi:10.1016/s1054-139x(01)00211-7 · Cited by 126
“The current shortcomings of these instruments include the lack of psychometric data from healthy or population samples [8,9,15–17], appropriateness of samples involved in their development [3,13,14,16,18], length [19,20], language [10,16,20], conceptual framework [14,21–23], and lack of dual respondent reports [6–10,1…”
BackgroundAerobic and anaerobic exercise capacity in adolescents with juvenile idiopathic arthritis
Lelieveld, O. T. H. M., van Brussel, M., Takken, T., van Weert, E., Leeuwen, M. A. V., & Armbrust, W. (2007) · Arthritis Care & Research · doi:10.1002/art.22897 · Cited by 121
Ruperto, N., Brunner, H. I., Quartier, P., Constantin, T., Wulffraat, N. M., Horneff, G., Kasapçopur, Ö., Schneider, R., Antón, J., Barash, J., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213150 · Cited by 112
Schanberg, L. E., Gil, K. M., Anthony, K. K., Yow, E., & Rochon, J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20952 · Cited by 111
“51 9 (17.6) Total no. of active joints 51 9.4 10.2 7.0 (2.0–12.0) Physician global assessment score, mm 51 31.5 25.6 21.0 (12.0–47.0) C-HAQ score 51 0.62 0.59 0.50 (0.13–0.88) ESR, mm/hour 51 23.24 26.05 12.00 (6.00–30.00) Platelet count, 103/ l 50 321.24 117.09 281.00 (252.00–353.00) Hematocrit 50 0.37 0.03 0.37 (0.3…”
BackgroundMethodInfluential
Metadata
- Authors
- Singh, G., Athreya, B. H., Fries, J. F., & Goldsmith, D. P.
- Affiliations
- Stanford Medicine (US)
- Children's Hospital of Philadelphia (US)
- St. Christopher's Hospital for Children (US)
- Corresponding author
- Singh, Gurkirpal
- ORCID
- Singh, Gurkirpal
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1994-12
- Volume
- 37
- Issue
- 12
- Pages
- 1761-1769
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2108075643
- Cited by
- 838
- References
- 20
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 24 · 2023: 26 · 2022: 22 · 2021: 38 · 2020: 36 · 2019: 33 · 2018: 79 · 2017: 27 · 2016: 25 · 2015: 23 · 2014: 29 · 2013: 36 · 2012: 37
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AM2 1393, 5r18am021393-11)
- Topics
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- juvenile idiopathic arthritis, functional status, Childhood Health Assessment Questionnaire, questionnaire adaptation, parent-reported outcomes, disability assessment, test-retest reliability, convergent validity, children
- MeSH terms
- Arthritis, Juvenile, Child, Child, Preschool, Disability Evaluation, Female, Health Status, Humans, Infant, Male, Parent-Child Relations, Surveys and Questionnaires, Regression Analysis, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.